期刊文献+

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease 被引量:6

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
下载PDF
导出
摘要 Neuroprotection and neuroregeneration are two of the most promising disease-modifying ther- apies for the incurable and widespread Parkinson's disease. In Parkinson's disease, progressive degeneration of nigrostriatal dopaminergic neurons causes debilitating motor symptoms. Neurotrophic factors play important regulatory roles in the development, survival and maintenance of specific neuronal populations. These factors have the potential to slow down, halt or reverse the loss of nigrostriatal dopaminergic neurons in Parkinsoffs disease. Several neurotrophic fac- tors have been investigated in this regard. This review article discusses the neurodevelopmental roles and therapeutic potential of three dopaminergic neurotrophic factors: glial cell line-derived neurotrophic factor, neurturin and growth/differentiation factor 5. Neuroprotection and neuroregeneration are two of the most promising disease-modifying ther- apies for the incurable and widespread Parkinson's disease. In Parkinson's disease, progressive degeneration of nigrostriatal dopaminergic neurons causes debilitating motor symptoms. Neurotrophic factors play important regulatory roles in the development, survival and maintenance of specific neuronal populations. These factors have the potential to slow down, halt or reverse the loss of nigrostriatal dopaminergic neurons in Parkinsoffs disease. Several neurotrophic fac- tors have been investigated in this regard. This review article discusses the neurodevelopmental roles and therapeutic potential of three dopaminergic neurotrophic factors: glial cell line-derived neurotrophic factor, neurturin and growth/differentiation factor 5.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第19期1708-1711,共4页 中国神经再生研究(英文版)
基金 supported by grants from the Irish Research Council(R13702 and R15897 SVH/AS/G’OK) the Health Research Board of Ireland(HRA/2009/127 GO’K/AS) Science Foundation Ireland(10/RFP/NES2786 GO’K)
关键词 Parkinson's disease NEUROPROTECTION neurotrophic factors nervous system development nigrostriatal dopaminergic neurons glial cell line-derived neurotrophic factor neurturin growth/differentiation factor 5 Parkinson's disease neuroprotection neurotrophic factors nervous system development nigrostriatal dopaminergic neurons glial cell line-derived neurotrophic factor, neurturin, growth/differentiation factor 5
  • 相关文献

参考文献34

  • 1Bartus RT, Baumann TL, Siffert J, Herzog CD, Alterman R, Boulis N, Turner DA, Stacy M, Lang AE, Lozano AM, Olanow CW (2013) Safe- ty/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients. Neurology 80:1698-1701.
  • 2Choi-Lundberg DL, Bohn MC (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res Dev Brain Res 85:80-88.
  • 3Clarkson ED, Zawada WM, Freed CR (1997) GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell Tissue Res 289:207-210.
  • 4Clayton KB, Sullivan AM (2007) Differential effects of GDF5 on the me- dial and lateral rat ventral mesencephalon. Neurosci Lett 427:132-137.
  • 5Costello DJ, O'Keeffe GW, Hurley FM, Sullivan AM (2012) Transplan- tation of novel human GDF-5-expressing CHO cells is neuroprotec- tive in models of Parkinson's disease. J Cell Mol Med 16:2451-2460.
  • 6Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, Bjorklund A (2011) GDNF fails to exert neuroprotection in a rat alpha-synudein model of Parkinson's disease. Brain 134:2302- 2311.
  • 7Eggert K, Schlegel J, Oertel W, Wurz C, Krieg JC, Vedder H (1999) Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Neurosci Lett 269:178- 182.
  • 8Gavin AM, Walsh S, Wyatt SL, O' Keeffe GW, Sullivan AM (2013) 6-Hy- droxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo. Neurosci Lett 561:176-181.
  • 9Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P (2003) Direct brain infusion of gila/cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589-595.
  • 10Granholm AC, Mott JL, Bowenkamp K, Eken S, Henry S, Hoffer BJ, Lapchak PA, Palmer MR, van Horne C, Gerhardt GA (1997) Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 116:29-38.

同被引文献10

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部